TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

30.30$ -1.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -145.0% – – – – – – – – +1,020.1% -130.6%
– +90.2% +104.5% +49.6% +61.5% +37.4% -2.6% -15.4% -29.7% -39.3% +29.9% -42.2%
– +2,170.7% +14.0% +94.1% -79.6% +358.9% +167.1% +499.0% -32.7% -21.9% +33.1% +10.3%
– – – – – – +871.1% +36.0% -51.3% – – –
– – – – – -114.9% – – – – +886.3% -115.3%
– +185.5% +6.7% +186.8% -80.0% +20.9% -28.1% -54.9% +58.9% +94.9% +20.5% -37.6%
– -8.5% – -133.1% – -107.1% – -374.1% +71.6% +95.4% +8,172.1% -96.6%
– – – – – – – – – – – –
– – – +0.0% -121.8% +0.0% – -109.5% +1.6% -100.0% – -100.0%
– +39,115.7% -99.9% +20,040.5% -99.5% +54,481.2% +110.3% +148.6% -49.5% -81.3% +1,165.2% -97.3%
– – – -138.8% – -221.5% – +159.1% -43.6% -61.0% -58.8% -32.2%
– -162.8% – – – – – – – – – -153.6%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?